Sarcopenia in NASH Cirrhosis
N
Niharika Samala, MD
Primary Investigator
Enrolling By Invitation
18-100 years
All
Phase
N/A
50 participants needed
3 Locations
Overview
This research aims understand the burden of sarcopenia and its association with hepatic decompensation in patients with cirrhosis caused by NAFLD, in particular post-menopausal women and compare to age matched males with and without type 2 diabetes.
Description
Participants will complete one study visit. During the visit, they will complete two questionnaires about health and alcohol consumption, have vital signs taken, undergo a FibroScan (similar to an ultrasound), body composition assessment, physical function tests, blood draw, and an optional MRI.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
NASH Cirrhosis
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
- Females who are post-menopausal, as defined as amenorrhea for 12 months
- Male or female willing and able to provide informed consent
- Wing and able to complete the FitCore study
- Diagnosis of or suspected to have NASH cirrhosis
Exclusion Criteria:
- Females who are not post-menopausal
- Unwilling or unable to follow study procedures
- Post-transplant of any organ
- Unwilling or unable to complete the FitCore study
- Claustrophobic or in possession of medical or medical debris residing in the body such that an MRI is contraindicated
Updated on
01 Aug 2024.
Study ID: 14498, GI-IIR-SARCOPENIA-NASH
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
